文献速递免疫规划卫生政策与健康促进

疫苗免疫原性与反应原性之间的关系:一项叙述性综述

The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review.
PubMed 文献 · Vaccine · 2025-10-28

该叙述性综述综合了不同疫苗平台和病原体下疫苗反应原性与免疫原性关系的证据,认为全身反应原性与体液免疫原性呈适度但一致的正相关,尤其见于mRNA新冠疫苗;局部反应预测性较弱;研究设计、人群和结局测量存在显著异质性,需统一工具和考虑接种前免疫状态的研究设计。

要点

  • 全身反应原性与体液免疫原性呈适度但一致的正相关,尤其见于mRNA新冠疫苗。
  • 局部反应对免疫反应的预测性不如全身反应一致。
  • 反应原性在年轻成人、女性及携带某些HLA等位基因者中更明显,这些因素也与更强免疫反应相关。

核心结论

  • 现有数据提示全身反应原性与体液免疫原性之间存在适度但一致的正相关,尤其对于mRNA新冠疫苗;与先天性和适应性细胞免疫的关联研究较少。

研究设计与样本

  • 叙述性综述,综合了多种疫苗平台和病原体下 examining 疫苗反应原性与免疫原性关系的证据。

主要发现

  • 全身反应原性与体液免疫原性呈适度但一致的正相关,尤其对于mRNA新冠疫苗。
  • 局部反应对免疫反应的预测性不如全身反应一致。
  • 反应原性在年轻成人、女性及携带某些HLA等位基因者中更明显,这些因素也与更强免疫反应相关。
  • 疫苗系列的基础免疫或加强剂量是否驱动更大的反应原性和免疫原性,似乎取决于疫苗是否为减毒活疫苗。
  • 研究设计、人群、结局测量和统计分析存在显著异质性。

临床怎么用

  • 理解先天免疫激活、耐受性与适应性免疫反应之间的机制联系,可为疫苗开发、临床试验终点和公共沟通策略提供信息。

局限性

  • 研究设计、人群、结局测量和统计分析存在显著异质性。
  • 需要统一工具来量化疫苗反应原性,以及考虑接种前免疫状态的研究设计,以区分真实关联与混杂因素。
  • 需要进一步研究以揭示疫苗相关症状的生物学基础及其在预测保护中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The relationship between vaccine reactogenicity and immunogenicity remains an underexplored but increasingly critical area of vaccinology. This narrative review synthesizes evidence examining this relationship across a diverse array of vaccine platforms and pathogens. The available data suggest a modest but consistent positive association between systemic reactogenicity and humoral immunogenicity, particularly for mRNA-based SARS-CoV-2 vaccines. Associations with innate and adaptive cellular immunity are less well studied. Local reactions are less consistently predictive of immune response than systemic ones. Reactogenicity appears more pronounced in younger adults, females, and those with certain HLA alleles-factors also associated with stronger immune responses. Whether the priming or booster dose of a vaccine series drives greater reactogenicity and immunogenicity appears to depend upon whether the vaccine is live-attenuated or not. However, substantial heterogeneity exists in study design, population, outcome measurement, and statistical analysis. This review emphasizes the need for harmonized tools to quantify vaccine reactogenicity and for study designs that account for pre-vaccination immune status to distinguish true associations from confounding factors and better clarify the relationship between post-vaccine symptoms and immunologic outcomes. Understanding the mechanistic links between innate immune activation, tolerability, and adaptive immune responses could inform vaccine development, clinical trial endpoints, and public communication strategies. As vaccine technologies evolve and tolerability becomes a differentiating factor, further research is needed to unravel the biological basis of vaccine-associated symptoms and their role in predicting protection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gromer DJ, Kalash S, Tanios R, et al. The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review. Vaccine. 2025. PMID: 41161041. doi:10.1016/j.vaccine.2025.127892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。